Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / BIOTECH ETF
-
Number of holders
-
82
-
Total 13F shares, excl. options
-
443K
-
Shares change
-
-50.7K
-
Total reported value, excl. options
-
$61.8M
-
Value change
-
-$5.72M
-
Put/Call ratio
-
0.2
-
Number of buys
-
27
-
Number of sells
-
-27
-
Price
-
$139.42
Significant Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q4 2019
93 filings reported holding BBH - VANECK ETF TRUST - BIOTECH ETF as of Q4 2019.
VANECK ETF TRUST - BIOTECH ETF (BBH) has 82 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 443K shares
.
Largest 10 shareholders include UBS Group AG (46.1K shares), MORGAN STANLEY (45.8K shares), MURPHY CAPITAL MANAGEMENT INC (36.6K shares), BANK OF AMERICA CORP /DE/ (32K shares), MOGY JOEL R INVESTMENT COUNSEL INC (24.2K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (20.3K shares), JANE STREET GROUP, LLC (20.2K shares), RAYMOND JAMES & ASSOCIATES (14.8K shares), BOSTON RESEARCH & MANAGEMENT INC (14.1K shares), and LPL Financial LLC (12.8K shares).
This table shows the top 82 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.